# Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults

> **NCT02562482** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 400 (actual)

## Conditions studied

- Chikungunya Virus Infection

## Interventions

- **BIOLOGICAL:** VRC-CHKVLP059-00-VP
- **OTHER:** VRC-PBSPLA043-00-VP

## Key facts

- **NCT ID:** NCT02562482
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-18
- **Primary completion:** 2018-03-06
- **Final completion:** 2018-03-06
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2020-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02562482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02562482, "Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02562482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*